NYSE: BMY - Bristol-Myers
Rentabilität für sechs Monate: +18.1%
Dividendenrendite: +4.56%
Sektor: Healthcare
Nachricht
18 november 17:57 Western drugmakers are still providing medicines to Russia
18 november 17:51 Drugmakers raised prices by 6.6% on average early this year
18 november 17:46 Stock futures trade mixed ahead of Fed decision
18 november 17:35 Bristol Myers to buy RayzeBio for about $4.1B
18 november 17:20 Warren Buffett's Berkshire Hathaway shakes up investment holdings
18 november 16:56 Bristol Myers to buy Karuna Therapeutics for $14B
